- NLM Digital Collections - Crizanlizumab, voxelotor, and L-glutamine for sickle cell disease : effectiveness and valuePublication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, March 12, 2020... care mL/min/1.73 m2 based on CKD EPI albuminuria (ACR) by Sickle Cell Disease formula Estimated Comparator: 3. Patients with ACR of ≥ 100 ...
1 results